BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Nooijer AH, Grondman I, Lambden S, Kooistra EJ, Janssen NAF, Kox M, Pickkers P, Joosten LAB, van de Veerdonk FL, Derive M, Gibot S, Netea MG; RCI-COVID-19 study group. Increased sTREM-1 plasma concentrations are associated with poor clinical outcomes in patients with COVID-19. Biosci Rep 2021;41:BSR20210940. [PMID: 34195785 DOI: 10.1042/BSR20210940] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Colonna M. The biology of TREM receptors. Nat Rev Immunol 2023;:1-15. [PMID: 36750615 DOI: 10.1038/s41577-023-00837-1] [Reference Citation Analysis]
2 Gonçalves GS, Correa-Silva S, Zheng Y, Avelar I, Montenegro MM, Ferreira AEF, Bain V, Fink TT, Suguita P, Astley C, Lindoso L, Martins F, Matsuo OM, Ferreira JCOA, Firigato I, de Toledo Gonçalves F, Fernanda B Pereira M, Artur A da Silva C, Carneiro-Sampaio M, Marques HHS, Palmeira P. Circulating sTREM-1 as a predictive biomarker of pediatric multisystemic inflammatory syndrome (MIS-C). Cytokine 2023;161:156084. [PMID: 36403563 DOI: 10.1016/j.cyto.2022.156084] [Reference Citation Analysis]
3 Husain S, Sage AT, Del Sorbo L, Cypel M, Martinu T, Juvet SC, Mariscal A, Wright J, Chao BT, Shamandy AA, Mousavi SH, Ma J, Wang B, Valero J, Liu M, Landes M, Balachandran S, Hudson K, Ngai M, Capuano M, Gelardi M, Lupia E, Marinowic DR, Friedrich FO, Schmitz CRR, Dos Santos LSM, Barbe-Tuana FM, Jones MH, Kain KC, Mazzulli T, Sabbah S, Keshavjee S. A biomarker assay to risk-stratify patients with symptoms of respiratory tract infection. Eur Respir J 2022;60. [PMID: 36104292 DOI: 10.1183/13993003.00459-2022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Matos ADO, Dantas PHDS, Queiroz HAGDB, Silva-sales M, Sales-campos H. TREM-2: friend or foe in infectious diseases? Critical Reviews in Microbiology 2022. [DOI: 10.1080/1040841x.2022.2146481] [Reference Citation Analysis]
5 Sharapova TN, Ivanova OK, Romanova EA, Sashchenko LP, Yashin DV. N-Terminal Peptide of PGLYRP1/Tag7 Is a Novel Ligand for TREM-1 Receptor. Int J Mol Sci 2022;23:5752. [PMID: 35628562 DOI: 10.3390/ijms23105752] [Reference Citation Analysis]
6 de Oliveira YLM, de Sá Resende A, Martins-filho PR, de Moura TR. Role of triggering receptor expressed on myeloid cells-1 (TREM-1) in COVID-19 and other viral pneumonias: a systematic review and meta-analysis of clinical studies. Inflammopharmacol. [DOI: 10.1007/s10787-022-00972-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 da Silva-Neto PV, de Carvalho JCS, Pimentel VE, Pérez MM, Toro DM, Fraga-Silva TFC, Fuzo CA, Oliveira CNS, Rodrigues LC, Argolo JGM, Carmona-Garcia I, Neto NT, Souza COS, Fernandes TM, Bastos VAF, Degiovani AM, Constant LF, Ostini FM, Feitosa MR, Parra RS, Vilar FC, Gaspar GG, da Rocha JJR, Feres O, Frantz FG, Gerlach RF, Maruyama SR, Russo EMS, Viana AL, Fernandes APM, Santos IKFM, Bonato VLD, Boechat AL, Malheiro A, Sadikot RT, Dias-Baruffi M, Cardoso CRB, Faccioli LH, Sorgi CA, On Behalf Of The Imunocovid Study Group. sTREM-1 Predicts Disease Severity and Mortality in COVID-19 Patients: Involvement of Peripheral Blood Leukocytes and MMP-8 Activity. Viruses 2021;13:2521. [PMID: 34960790 DOI: 10.3390/v13122521] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]